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A series of Tn5 transposases (Tnp’s) with mutations at the conserved amino acid position W450, which was
structurally predicted to be important for synapsis, have been generated and characterized. This study
demonstrates that W450 is involved in hydrophobic (and possibly aromatic) contacts within the Tnp monomer
that negatively regulate synaptic complex formation.
Tn5 transposase (Tnp) is a member of the retroviral inte-
grase superfamily of proteins. This superfamily includes other
Tnp’s, as well as proteins such as human immunodeficiency
virus type 1 integrase and the RAG-1 recombinase of V(D)J
recombination. The members of this superfamily share many
mechanistic details, as well as structurally conserved active
sites (4, 6, 12). In order to catalyze DNA movements, these
proteins adopt highly ordered protein-DNA synaptic com-
plexes. Based on structural studies with Tn5 Tnp, it is known
that these complexes involve large numbers of protein-protein
and protein-DNA contacts (3) and generally involve the rear-
rangement of the proteins. The catalytic steps of Tn5 transpo-
sition are depicted in Fig. 1.
Tn5 transposition is a tightly regulated process, as excessive
transposition activity would likely lead to instability of the host
cell genome. Previous studies led to a model in which Tn5 Tnp
monomers manifest an intramolecular interaction between the
N terminus, containing end sequence (ES) DNA binding res-
idues, and the C terminus, containing the protein-protein
dimerization domain, that inhibits synaptic complex formation
(9, 15). Tn5 Tnp is monomeric in solution and binds to ES
DNA substrates only as a dimer (5, 9, 15). Tn5 inhibitor Inh
(lacking 55 N-terminal residues) exists as a dimer in solution,
suggesting that the N terminus of free Tnp blocks dimerization
(9). When the C-terminal dimerization domain is removed
from Tnp (in a C-terminal truncation mutant protein, 369),
Tnp is unable to form dimers or synaptic complexes (14, 16,
17). However, 369 is able to bind to ES DNA as a monomer
(17). Thus, the removal of the C terminus allows ES DNA
binding. It is likely that C-terminal deletions of Mu and IS911
transposases also enhance ES DNA binding (1, 7).
In this study, we investigated the role of amino acid W450 in
transposition and demonstrated that this residue is inhibitory
for synapsis and may contribute to the N terminus-C terminus
inhibitory interaction. W450 is conserved across IS50/Tn5
transposase-related proteins (11). W450 is located at the be-
ginning of the C-terminal -helix (3) that is spatially dislocated
by the hyperactive L372P mutation (10, 15). W450 is also
located adjacent to a previously identified, modestly hyperac-
tive mutation, E451Q (8). Mutations at position 450 were in-
troduced via site-directed mutagenesis using the QuikChange
site-directed mutagenesis kit (Stratagene). All control and mu-
tant Tnp constructs in this study contained three hyperactive
mutations, E54K (19), M56A, and L372P (15), unless other-
wise specified. All Tnp mutant forms were overexpressed and
purified as previously described (2).
In vivo analysis of W450 substitutions. The in vivo activities
of the proteins with W450 substitutions were analyzed utilizing
a qualitative, colorimetric papillation assay performed as pre-
viously described (19). In this assay, transposition levels were
estimated by using the total number of blue papillae and mu-
tant Tnp’s were compared to the control Tnp.
Compared to the control, the W450C, W450S, and W450R
mutant forms demonstrated a hyperpapillation phenotype af-
ter 48 h incubation (Fig. 2A). It is important that these
mutant proteins not only displayed a net increase in total
papillae but also formed papillae faster than the control Tnp (they
exhibited blue papillae 8 h earlier than the control) (data not
shown). When the tryptophan group was replaced with another
hydrophobic, aromatic functional group through a W450F mu-
tation, the proteins formed papillae at the same relative rate as
the control and arrived at the same relative amount of total
papillae formed after 48 h. These results indicate that the
hydrophobic (and possibly aromatic) properties of residue
W450 are deleterious for transposition in vivo.
The effect of the W450C mutation was also investigated in
relation to the mutation that is likely to be involved in a spatial
distortion of the C-terminal -helix and that may compromise
the N terminus-C terminus inhibitory interaction, L372P (10,
15). W450C mutant Tnp (lacking L372P) was shown to be
hyperactive versus a control Tnp lacking both the W450C and
L372P mutations (Fig. 2B). This result indicates that the mu-
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tations at position 450 are independent of (and likely synergis-
tic with) the L372P mutation and that mutations at both sites
are likely to be involved in overcoming the inhibitory confor-
mation.
The primary mechanistic step of transposition affected by
W450 mutations is synaptic complex formation. This study was
conducted with the belief that position W450 is involved in
inhibitory contact(s) with the N terminus of the Tnp. There-
fore, it stood to reason that mutations at this position would
have large effects on synaptic complex formation. This assump-
tion was assayed by measuring the effects of the mutant Tnp’s
on paired-end complex (PEC) formation. The PEC is an ex-
perimental analog of the synaptic complex. Tnp was incubated
with fluorescently labeled 60-bp oligonucleotides containing
the hyperactive 19-bp mosaic-end (ME) ES, and PECs were
fractionated from free DNA by means of native polyacrylam-
ide gel electrophoresis (PAGE) as previously described (13).
Tnp forms with substitutions that replaced the tryptophan
group that were shown to be hyperactive for in vivo transpo-
sition led to dramatic increases in synaptic complex formation
in vitro. The hyperactive W450C, W450S, and W450R mutant
proteins formed 81, 70, and 76% PECs (Fig. 3, lanes W450C,
W450S, and W450R), respectively, which represented in-
creases in complex formation of 1.8-, 1.5-, and 1.8-fold, respec-
tively, compared to that by the control, and none of the mutant
Tnp’s displayed any ability to bind to DNA in a monomeric
fashion. Consistent with in vivo transposition data, the replace-
ment of the tryptophan group with a phenyl group in the
W450F mutant Tnp led to control-like activity for PEC forma-
tion (Fig. 3, lanes W450F).
The results of the PEC formation assay indicate that the
native amino acid W450 is deleterious for synaptic complex
formation. Furthermore, these results indicate that this tryp-
tophan is likely to be involved in hydrophobic (and possibly
aromatic) contacts which are most likely responsible for the
inhibition of synaptic complex formation.
The W450 Tnp mutant forms were further investigated in
vitro to determine if the mutations had additional effects on
the remaining mechanistic steps of transposition: cleavage and
strand transfer (current experimental techniques do not allow
for the independent analysis of target capture and strand trans-
fer). The cleavage assay was performed by incubating mutant
Tnp’s with fluorescently labeled 60-bp oligonucleotides con-
taining the 19-bp ME to form PECs and then adding 10 mM
Mg2 to induce cleavage of the transposon from donor back-
bone (dbb) DNA as previously described (13). The cleavage
reaction gives rise to two products: the single-end-break prod-
uct (SEB) that represents the cleavage of one dbb-ES junction
and the double-end-break product (DEB) that represents the
cleavage of both dbb-ES junctions. The three protein-DNA
complexes were separated by fractionation of the PECs from
FIG. 1. Tn5 transposition mechanism. Transposition is initiated by
Tnp binding to the transposon-specific ESs and the formation of a
highly ordered nucleoprotein complex (synaptic complex) through a
process called synapsis. The synaptic complex contains two protomers
of Tnp, which exist as a dimer, and two ESs. Catalytic cleavage occurs
when an activated water molecule coordinated by Mg2 nicks the
transferred DNA strand (TS) on both sides of the transposon, through
a nucleophilic attack, forming a 3-hydroxyl group. The free 3-hy-
droyxl group acts as a nucleophile and cleaves the nontransferred
DNA strand (NT), forming a hairpin. A second activated water mol-
ecule resolves the hairpin, resulting in a double-stranded DNA cleav-
age product. The postcleavage synaptic complex is now free to bind to
target DNA through target capture. The 3-hydroxyl group of the
transposon end attacks the phosphodiester backbone of target DNA
during strand transfer. A 9-bp duplication in the target results, due to
the staggered strand transfer reactions followed by DNA repair by host
enzymes.
FIG. 2. In vivo (papillation) transposition assay. Transposition lev-
els were estimated by using the total number of blue papillae, and
mutant Tnp’s were compared to control Tnp to qualitatively assess
transposase activity levels. (A) The W450F mutant Tnp (WF450)
showed the same relative transposition activity as the control, indicat-
ing that W450 is involved in hydrophobic (and possibly aromatic)
contacts. The W450C (WC450), W450S, and W450R (WR450) mutant
Tnp’s led to an 6-fold increase in transposition activity and pro-
ceeded to catalyze transposition (form blue papillae) 8 h before the
control (EK/LP) (data not shown). (B) Transposition activity levels of
the W450C mutant Tnp (lacking L372P) and the control were com-
pared. The W450C mutant Tnp was shown to be less active in trans-
position than control Tnp, but the mutation at position 450 still led to
a general increase in transposition activity compared to that of Tnp
containing the E54K (EK54) and M56A (MA56) mutations. This find-
ing indicates that the increase in transposition activity conferred by
mutations at position 450 is not dependent on the presence of the
L372P (LP372) mutation.
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free DNA by means of native PAGE as previously described
(13).
With the exception of that by the W450R mutant Tnp, cleav-
age was largely unaffected by mutations at position W450. At
each mechanistic step of cleavage, W450C, W450F, and
W450S mutant Tnp’s proceeded at rates that were comparable
with that of the control Tnp, and the mutant forms proceeded
to the same end point in the reactions (Fig. 4). Surprisingly, the
W450R mutant Tnp led to a general increase in cleavage at
each mechanistic step of cleavage (Fig. 4). It is possible that
larger structural changes were introduced into the PEC by
substituting the large, charged guanidine group for the wild-
type tryptophan group. These structural changes may in turn
FIG. 4. Cleavage assay. (A) Cleavage activity was assessed by forming
PECs with fluorescently labeled DNA oligomers (60-mer) at 37°C for 1 h
as previously described, with the addition of 100 g of tRNA/ml to the
reaction buffer (13). After complex formation, Mg2 was added to a final
concentration of 10 mM to catalyze the cleavage mechanism. Cleavage results
in two products: the SEB and the DEB. Cleavage products, along with
unreacted PEC, were visualized via 6% native PAGE. The time course
proceeded for 1 h. These experiments were repeated three times, and the
gel shown is representative of all of these experiments. EK/LP, control Tnp.
(B) The percentage of labeled oligonucleotide in each complex (the PEC,
SEB, or DEB) relative to the total amount of the substrate contained in the
complex was determined. With the exception of the W450R mutant Tnp,
the Tnp’s with mutations at position W450 behaved similarly to the con-
trol Tnp. The mutant Tnp forms had approximately the same rates and
total yields of PEC cleavage, SEB formation and destruction, and DEB
formation. The W450R mutant Tnp led to an increase in the rate of
cleavage over that of the control, forming SEB complexes and converting
SEB complexes into DEB complexes faster than the control. This increased
rate of cleavage was repeatable over all three separate experiments. The data
indicate that position W450 does not play a large role in the cleavage mech-
anism but that the substitution of a large charged amino acid leads to hyper-
activity, possibly through steric interference with the W450 binding partners.
FIG. 3. PEC formation assay. (A) PECs were formed by incubating
Tnp with double-stranded, fluorescently labeled DNA oligomers (60-
mers) for 1 h at 37°C as previously described, with the addition of 100
g of tRNA/ml to the reaction buffer (13). Products were visualized via
6% native PAGE. These experiments were repeated three times, and
the gel shown is representative of all of these experiments. EK/LP,
control Tnp; () protein, no protein. (B) PEC formation was quanti-
fied by comparing the amount of labeled DNA in the PEC to the total
amount of labeled DNA. These experiments were repeated three
times, and the results shown are representative of all of these experi-
ments. PEC formation was enhanced for W450C, W450S, and W450R
mutant Tnp’s, which formed 81, 70, and 76% PECs, respectively, in
contrast to the control Tnp, which formed 46% PECs. These differ-
ences represent increases of 1.8-, 1.5-, and 1.8-fold, respectively. The
W450F mutant Tnp formed 38% PECs, which represents an 18%
reduction compared to the control Tnp. Increases in PEC formation
were most likely due to the removal of the hydrophobic (and possibly
aromatic) contacts between amino acid W450 and its binding partners,
presumably on the N-terminal portion of the Tnp monomer. In this
model, the removal of these contacts shifts the conformation equilib-
rium of the Tnp monomer away from the inhibitory conformation.
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have led to a Tnp conformation that was more reactive for
cleavage. Except for the W450R result, these results indicate
that residue W450 does not play a large role in cleavage.
The strand transfer capabilities of the mutant Tnp’s were
assayed by preforming PECs with fluorescently labeled 40-bp
oligonucleotides containing the ME as previously described
(13). Following PEC formation, the reaction mixtures were
incubated at 20°C for 30 min. Strand transfer was induced with
the addition of 10 mM Mg2 and 15 nM supercoiled pUC19
DNA (to serve as target DNA) as previously described (13).
Strand transfer leads to two products: an open-circle single-
end strand transfer product and a linear double-end strand
transfer product. These products were separated from unre-
acted substrate DNA via electrophoresis on a 2% agarose gel.
Tnp’s with mutations at residue W450 have strand transfer
activities very similar to that of the control Tnp. The three
mutant Tnp’s that have been shown to be hyperactive for in
vivo transposition and synapsis (the W450C, W450R, and
W450S mutant forms) were slightly hyperactive for total strand
transfer, with each showing an increase of 10% compared to
that by the control Tnp (data not shown). The W450F mutant
Tnp showed a slight deficiency in strand transfer (10% de-
crease in total strand transfer activity) compared to that by the
control (data not shown). These slight changes in strand trans-
fer activity led us to conclude that residue W450 does not play
a significant role in either target capture or strand transfer.
Model for W450 activity in Tn5 transposition. It has been
shown previously that W450 is inhibitory for transposition in
vivo, and this inhibition seems to act at the level of synaptic
complex formation that is critical in controlling the initiation of
transposition. Position W450 is likely to be involved in hydro-
phobic (possibly aromatic) interactions, as replacement with
phenylalanine leads to wild-type activity levels. These results
are in agreement with the prediction that W450 is involved in
the N terminus-C terminus inhibitory interaction. It is believed
that by removing the tryptophan functional group, the C-ter-
minal -helix is better able to move away from the N terminus.
In this model, W450 serves as a tether that keeps the helix in
proximity to the N terminus.
One explanation for the effect of residue W450 on transpo-
sition posits that the W450 contacts other, presumably N-ter-
minal, residues in monomeric Tn5 Tnp. It is difficult to predict
the residues that W450 would contact prior to DNA binding, as
no X-ray crystal structure of the full-length, monomeric, DNA-
free form of the Tnp exists. However, one candidate region is
located near residue 40; thus, we introduced mutations into
position 40 and nearby residues and examined the resulting
mutant proteins for effects on Tn5 transposition. All of these
mutant transposases were defective in transposition. This re-
sult is not surprising given that ES binding contacts are located
in the same region (3, 18). Therefore, the results of these
analyses were uninformative about the various N-terminal res-
idues potentially playing a role in the N terminus-C terminus
inhibitory interactions because the negative effects of the loss
of ES binding would be epistatic for any possible beneficial
effects on the Tnp conformation.
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